| Novartis: Afinitor Benefits Patients With Pancreatic Tumors - Wall Street Journal |
|
|
Wall Street JournalIn the European Union, tablets are approved for the treatment of patients with advanced renal cell carcinoma whose disease has progressed on or after ...Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in ... read more |